Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

People using Ozempic say they are losing their desire to drink. It’s anecdotal evidence right now, but this would be a game-changer for those who are trying to break free from addiction. Drugs like ...

Patent and trademark enforcement has become an important economic tool for entrepreneurs.

Shapiro, a Democrat entering his third budget negotiation, speaks of the process in positive yet pragmatic terms. He ...

Novo Nordisk's GLP-1 agonist semaglutide, used to treat diabetes and obesity, may cause a serious eye condition that can lead ...

Ozempic and other GLP-1 drugs have forever altered the way people view, manage, and speak about obesity. However, it’s ...

Among dozens of new laws signed this week by Gov. Jared Polis are consumer-friendly rules making it easier to cancel services ...

An Israeli study has found that patients taking the weekly jab - or similar drugs - were twice as likely to suffer from a ...

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

GLP-1 drugs like Ozempic are transforming weight loss and diabetes management. But no good deed goes unpunished, and the ...

The reactionary blogger’s call for a monarch to rule the country once seemed like a joke. Now the right is ready to bend the ...